Related references
Note: Only part of the references are listed.Effects of torcetrapib in patients at high risk for coronary events
Philip J. Barter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cholesteryl ester transfer protein gene haplotypes, plasma high-density lipoprotein levels and the risk of coronary heart disease
Pamela A. McCaskie et al.
HUMAN GENETICS (2007)
A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies
D. A. Tregouet et al.
BIOINFORMATICS (2007)
CETP inhibition in cardiovascular risk management: a critical appraisal
R. P. F. Dullaart et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE* 3-Leiden mice
Marit Westerterp et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Plasma cholesteryl ester transfer protein concentrations predict cardiovascular events in patients with coronary artery disease treated with pravastatin
P. Marschang et al.
JOURNAL OF INTERNAL MEDICINE (2006)
HDL as a target in the treatment of atherosclerotic cardiovascular disease
P Linsel-Nitschke et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Haploview: analysis and visualization of LD and haplotype maps
JC Barrett et al.
BIOINFORMATICS (2005)
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
JD Curb et al.
JOURNAL OF LIPID RESEARCH (2004)
In-depth haplotype analysis of ABCA1 gene polymorphisms in relation to plasma ApoA1 levels and myocardial infarction
DA Tregouet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans
CC Schwartz et al.
JOURNAL OF LIPID RESEARCH (2004)
Antiinflammatory properties of HDL
PJ Barter et al.
CIRCULATION RESEARCH (2004)
Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS)
AHEM Klerkx et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2004)
The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease
JF Carlquist et al.
AMERICAN HEART JOURNAL (2003)
Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease
S Blankenberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Haplotype analysis of the CETP gene:: not TaqIB, but the closely linked-629C→A polymorphism and a novel promoter variant are independently associated with CETP concentration
AHEM Klerkx et al.
HUMAN MOLECULAR GENETICS (2003)
Share Paper
